or Try an Advanced Search...

    Rna Interference Stocks List

    Symbol Grade Name % Change
    BNTC A Benitec Biopharma Limited 3.90
    ALNY C Alnylam Pharmaceuticals, Inc. 2.75
    ABUS D Arbutus Biopharma Corporation 2.99
    SLN F Silence Therapeutics Plc 2.20
    ARWR F Arrowhead Research Corporation 1.35
    View As Page of Charts
    Related Industries: Biotechnology Drug Manufacturers - Specialty & Generic
    Related Stock Lists: Biopharmaceutical Gene Expression Hepatitis B RNA Amyloid Amyloidosis Biology Biotechnology Cholesterol Gene Silencing Huntington's Disease Hypercholesterolemia Liver Cancer Molecular Biology Small Interfering Rna Transthyretin Acid Acute Intermittent Porphyria Acute Lymphoblastic Leukemia Ai Technology

    Related ETFs - A few ETFs which own one or more of the above listed Rna Interference stocks.

    Symbol Grade Name Weight
    GNOM F Global X Genomics & Biotechnology ETF 10.8
    HRTS D Tema Cardiovascular and Metabolic ETF 8.18
    PBE C PowerShares Dynamic Biotech & Genome 5.57
    MNTL D Tema Neuroscience and Mental Health ETF 4.96
    MEDX D Horizon Kinetics Medical ETF 4.6
    View all Rna Interference ETFs...
    Compare ETFs
    Compare HRTS to MEDX Compare MNTL to MEDX Compare PBE to MEDX

        Rna Interference Stocks Recent News

        Date Stock Title
        Nov 1 ALNY Alnylam Q3 Loss In Line With Estimates, Revenues Miss, Stock Down
        Nov 1 ALNY Alnylam Pharmaceuticals Third Quarter 2024 Earnings: EPS Beats Expectations, Revenues Lag
        Nov 1 ARWR Arrowhead Pharmaceuticals Launches New Disease Awareness Campaign, ‘We’ll Get There Soon,’ to Inspire Hope for the Rare Disease Community Affected by Familial Chylomicronemia Syndrome
        Nov 1 ALNY Alnylam Pharmaceuticals Inc (ALNY) Q3 2024 Earnings Call Highlights: Strong Revenue Growth and ...
        Nov 1 ALNY Decoding Alnylam Pharmaceuticals Inc (ALNY): A Strategic SWOT Insight
        Nov 1 ALNY Q3 2024 Alnylam Pharmaceuticals Inc Earnings Call
        Oct 31 ALNY Alnylam Pharmaceuticals, Inc. 2024 Q3 - Results - Earnings Call Presentation
        Oct 31 ALNY Alnylam Pharmaceuticals, Inc. (ALNY) Q3 2024 Earnings Call Transcript
        Oct 31 ALNY Alnylam (ALNY) Reports Q3 Earnings: What Key Metrics Have to Say
        Oct 31 ALNY Alnylam Pharmaceuticals (ALNY) Reports Q3 Loss, Lags Revenue Estimates
        Oct 31 ALNY Alnylam: Q3 Earnings Snapshot
        Oct 31 ALNY Alnylam Pharmaceuticals Non-GAAP EPS of -$0.50 misses by $0.11, revenue of $500.92M misses by $26.1M
        Oct 31 ALNY Alnylam Pharmaceuticals Reports Third Quarter 2024 Financial Results and Highlights Recent Period Activity
        Oct 31 SLN Is Silence Therapeutics plc (SLN) a Promising Gene Editing Stock?
        Oct 30 ALNY Alnylam Pharmaceuticals Q3 2024 Earnings Preview
        Oct 30 ALNY Cognizant signs deal to enhance Alnylam’s IT infrastructure
        Oct 30 ALNY Alnylam to Showcase Latest Data from TTR Franchise and Hypertension Program at American Heart Association Scientific Sessions 2024
        Oct 28 SLN We're Hopeful That Silence Therapeutics (NASDAQ:SLN) Will Use Its Cash Wisely
        Oct 28 ALNY Krystal Biotech, Inc. (KRYS) to Report Q3 Results: Wall Street Expects Earnings Growth
        Oct 28 ALNY Seeking Clues to Alnylam (ALNY) Q3 Earnings? A Peek Into Wall Street Projections for Key Metrics
        Related Industries: Biotechnology Drug Manufacturers - Specialty & Generic
        Related Stock Lists: Biopharmaceutical Gene Expression Hepatitis B RNA Amyloid Amyloidosis Biology Biotechnology Cholesterol Gene Silencing Huntington's Disease Hypercholesterolemia Liver Cancer Molecular Biology Small Interfering Rna Transthyretin Acid Acute Intermittent Porphyria Acute Lymphoblastic Leukemia Ai Technology
        Rna Interference

        RNA interference (RNAi) is a biological process in which RNA molecules inhibit gene expression or translation, by neutralizing targeted mRNA molecules. RNAi is a natural process in which small interfering RNA (siRNA), microRNA (miRNA), or short hairpin RNA (shRNA) molecules bind to specific mRNA molecules and either degrade them or inhibit their translation into proteins. RNAi is used in research, biotechnology, and medicine to silence the expression of specific genes.

        Browse All Tags